Future Innovations

Abiomed is constantly developing innovative products that are smaller, smarter and better connected

Abiomed has set itself the task of offering patients and healthcare providers the highest quality technology and optimal, cost-effective solutions. We achieve this by tirelessly exploring new ideas and approaches that enable us to meet new clinical challenges for our customers and patients.

Future Direction of Impella® Technology

Small

Break the small-bore barrier with Impella technology compatible with small-bore access and closure techniques

Smart

Improve patient outcomes by using real-time intelligence to optimize positioning, management and weaning

Connected

Impella Connect® and cloud-based artificial intelligence (AI) allow clinicians to stay informed and connected to help guide clinical decision-making

Investing in Clinical Data

Abiomed is committed to improving patient outcomes by leading in clinical research and real-world evidence. Abiomed supports clinical research and collects real-world data to improve patient outcomes through the cVAD Study®, the Impella Quality (IQ) Database, 24/7 clinical support, and on-going FDA pre- and post-market approval studies.

NPS-2607

This information is intended for use by customers, patients, and healthcare professionals in Europe only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside Europe, and the information from other sites you visit may not be appropriate for use in Europe.